Parsons PG - Search Results

1

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.

Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM, Green AC, Boyle GM. Newton TR, et al. Among authors: parsons pg. Int J Cancer. 2006 Aug 15;119(4):875-83. doi: 10.1002/ijc.21823. Int J Cancer. 2006. PMID: 16557592 Clinical Trial.

2

Novel markers for poor prognosis in head and neck cancer.

Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG, Coman WB. Chin D, et al. Among authors: parsons pg. Int J Cancer. 2005 Feb 20;113(5):789-97. doi: 10.1002/ijc.20608. Int J Cancer. 2005. PMID: 15499618

3

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.

Herath NI, Spanevello MD, Sabesan S, Newton T, Cummings M, Duffy S, Lincoln D, Boyle G, Parsons PG, Boyd AW. Herath NI, et al. Among authors: parsons pg. BMC Cancer. 2006 Jun 1;6:144. doi: 10.1186/1471-2407-6-144. BMC Cancer. 2006. PMID: 16737551 Free PMC article.

4

Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.

Merritt MA, Parsons PG, Newton TR, Martyn AC, Webb PM, Green AC, Papadimos DJ, Boyle GM. Merritt MA, et al. Among authors: parsons pg. BMC Cancer. 2009 Oct 23;9:378. doi: 10.1186/1471-2407-9-378. BMC Cancer. 2009. PMID: 19849863 Free PMC article.

5

Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA. Dong Y, et al. Among authors: parsons pg. Cancer Res. 2010 Apr 1;70(7):2624-33. doi: 10.1158/0008-5472.CAN-09-3415. Epub 2010 Mar 23. Cancer Res. 2010. PMID: 20332224

6

p53 expression and risk factors for cutaneous melanoma: a case-control study.

Whiteman DC, Parsons PG, Green AC. Whiteman DC, et al. Among authors: parsons pg. Int J Cancer. 1998 Sep 11;77(6):843-8. doi: 10.1002/(sici)1097-0215(19980911)77:6<843::aid-ijc8>3.0.co;2-u. Int J Cancer. 1998. PMID: 9714052

7

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis.

Dong Y, Walsh MD, McGuckin MA, Gabrielli BG, Cummings MC, Wright RG, Hurst T, Khoo SK, Parsons PG. Dong Y, et al. Among authors: parsons pg. Int J Cancer. 1997 Feb 20;74(1):57-63. doi: 10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f. Int J Cancer. 1997. PMID: 9036870

8

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer.

Dong Y, Walsh MD, McGuckin MA, Cummings MC, Gabrielli BG, Wright GR, Hurst T, Khoo SK, Parsons PG. Dong Y, et al. Among authors: parsons pg. Int J Cancer. 1997 Aug 22;74(4):407-15. doi: 10.1002/(sici)1097-0215(19970822)74:4<407::aid-ijc8>3.0.co;2-z. Int J Cancer. 1997. PMID: 9291430

9

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, Gardner JM, Le TT, Lenarczyk A, Aylward JH, Parsons PG. Ogbourne SM, et al. Among authors: parsons pg. Cancer Res. 2004 Apr 15;64(8):2833-9. doi: 10.1158/0008-5472.can-03-2837. Cancer Res. 2004. PMID: 15087400

10

Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.

Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG, Coman WB. Chin D, et al. Among authors: parsons pg. Laryngoscope. 2005 Jul;115(7):1239-42. doi: 10.1097/01.MLG.0000164715.86240.55. Laryngoscope. 2005. PMID: 15995513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters